Plancorp LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Sell
643
-448
-41% -$215K 0.01% 311
2026
Q1
$541K Sell
1,091
-29
-3% -$15.7K 0.02% 217
2025
Q4
$649K Buy
1,120
+51
+5% +$28.8K 0.02% 188
2025
Q3
$518K Buy
1,069
+140
+15% +$65.2K 0.02% 219
2025
Q2
$377K Sell
929
-45
-5% -$18.8K 0.01% 262
2025
Q1
$485K Buy
974
+444
+84% +$240K 0.02% 211
2024
Q4
$276K Sell
530
-168
-24% -$92.4K 0.01% 264
2024
Q3
$431K Buy
698
+140
+25% +$82.9K 0.02% 204
2024
Q2
$309K Sell
558
-7
-1% -$4.01K 0.01% 230
2024
Q1
$328K Buy
565
+71
+14% +$39.8K 0.01% 220
2023
Q4
$262K Buy
494
+78
+19% +$37.8K 0.01% 232
2023
Q3
$211K Buy
+416
New +$222K 0.01% 245
2023
Q2
Sell
-402
Closed -$232K 258
2023
Q1
$232K Buy
+402
New +$227K 0.01% 229
2022
Q4
Sell
-415
Closed -$210K 237
2022
Q3
$210K Buy
415
+14
+3% +$7.83K 0.01% 216
2022
Q2
$218K Buy
401
+10
+3% +$5.5K 0.01% 223
2022
Q1
$231K Buy
391
+34
+10% +$19.5K 0.02% 225
2021
Q4
$238K Sell
357
-1
-0.3% -$624 0.02% 220
2021
Q3
$205K Buy
+358
New +$196K 0.01% 222

Other funds holding TMO

Plancorp LLC's TMO Position: Q2 2026 in Review

Plancorp LLC reduced its Thermo Fisher Scientific (TMO) stake by 41% in Q2 2026, selling an estimated $215K and leaving 643 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #311.

Plancorp LLC first reported a position in TMO in Q3 2021 and has held it in 18 quarters since. The position peaked at $649K in Q4 2025. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Plancorp LLC held 643 shares of Thermo Fisher Scientific worth $340K as of Q2 2026.
  • Plancorp LLC sold 448 Thermo Fisher Scientific shares in Q2 2026, an estimated $215K.
  • Thermo Fisher Scientific made up 0.01% of Plancorp LLC's portfolio in Q2 2026, its #311 holding.
  • Plancorp LLC first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 18 quarters since.
  • Plancorp LLC's Thermo Fisher Scientific position peaked at $649K in Q4 2025.
  • 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.